These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 25319433)

  • 1. Differential sensing of MAP kinases using SOX-peptides.
    Zamora-Olivares D; Kaoud TS; Jose J; Ellington A; Dalby KN; Anslyn EV
    Angew Chem Int Ed Engl; 2014 Dec; 53(51):14064-8. PubMed ID: 25319433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexing the Quantitation of MAP Kinase Activities Using Differential Sensing.
    Zeng L; Kaoud TS; Zamora-Olivares D; Bohanon AL; Li Y; Pridgen JR; Ekpo YE; Zhuang DL; Nye JR; Telles M; Winkler M; Rivera S; Marini F; Dalby KN; Anslyn EV
    J Am Chem Soc; 2022 Mar; 144(9):4017-4025. PubMed ID: 35195411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-situ generation of differential sensors that fingerprint kinases and the cellular response to their expression.
    Zamora-Olivares D; Kaoud TS; Dalby KN; Anslyn EV
    J Am Chem Soc; 2013 Oct; 135(39):14814-20. PubMed ID: 23991633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of docking motifs in MAP-kinases and nuclear receptors.
    Burgermeister E; Lanzendoerfer M; Scheuer W
    J Biomol Struct Dyn; 2003 Apr; 20(5):623-34. PubMed ID: 12643765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the control of MAP kinase pathways.
    English J; Pearson G; Wilsbacher J; Swantek J; Karandikar M; Xu S; Cobb MH
    Exp Cell Res; 1999 Nov; 253(1):255-70. PubMed ID: 10579927
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystallization of MAP kinases.
    Lee SJ; Zhou T; Goldsmith EJ
    Methods; 2006 Nov; 40(3):224-33. PubMed ID: 16829129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ; Smith MF; Goldberg JB
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
    Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
    Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.
    Tanoue T; Maeda R; Adachi M; Nishida E
    EMBO J; 2001 Feb; 20(3):466-79. PubMed ID: 11157753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of MAP kinase activation under acidic condition in feline esophageal smooth muscle cells.
    Park SY; Lee YJ; Min Y; Kim HR; Jeong JH; Sohn UD
    Arch Pharm Res; 2011 Oct; 34(10):1759-68. PubMed ID: 22076776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
    Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
    Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation and properties of MAPKs.
    Raman M; Chen W; Cobb MH
    Oncogene; 2007 May; 26(22):3100-12. PubMed ID: 17496909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinases and their role in regulation of cellular processes.
    Strnisková M; Barancík M; Ravingerová T
    Gen Physiol Biophys; 2002 Sep; 21(3):231-55. PubMed ID: 12537349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinases regulate vascular reactivity after hemorrhagic shock through myosin light chain phosphorylation pathway.
    Yang G; Li T; Xu J; Peng X; Liu L
    J Trauma Acute Care Surg; 2013 Apr; 74(4):1033-43. PubMed ID: 23511142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.
    Roux PP; Blenis J
    Microbiol Mol Biol Rev; 2004 Jun; 68(2):320-44. PubMed ID: 15187187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine.
    Warthaka M; Adelmann CH; Kaoud TS; Edupuganti R; Yan C; Johnson WH; Ferguson S; Tavares CD; Pence LJ; Anslyn EV; Ren P; Tsai KY; Dalby KN
    ACS Med Chem Lett; 2015 Jan; 6(1):47-52. PubMed ID: 25589929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
    Goetz EM; Ghandi M; Treacy DJ; Wagle N; Garraway LA
    Cancer Res; 2014 Dec; 74(23):7079-89. PubMed ID: 25320010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.